Achievement of Dual Low-Density Lipoprotein Cholesterol and High-Sensitivity C-Reactive Protein Targets More Frequent With the Addition of Ezetimibe to Simvastatin and Associated With Better Outcomes in IMPROVE-IT
Bohula E A, Giugliano R P, Cannon C P, et al. Circulation Published online Sept 1, 2015 http://circ.ahajournals.org/content/early/2015/08/31/CIRCULATIONAHA.115.018381.abstract?papetoc
Leggi